PCV74 COST-EFFECTIVENESS OF STATIN THERAPY FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS PREDICTED BY THE REYNOLDS RISK SCORE IN HEALTHY MEN AND WOMEN AGED 40 TO 80 YEARS OF AGE
May 1, 2010, 00:00
10.1016/S1098-3015(10)72793-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)72793-5/fulltext
Title :
PCV74 COST-EFFECTIVENESS OF STATIN THERAPY FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS PREDICTED BY THE REYNOLDS RISK SCORE IN HEALTHY MEN AND WOMEN AGED 40 TO 80 YEARS OF AGE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72793-5&doi=10.1016/S1098-3015(10)72793-5
First page :
Section Title :
Open access? :
No
Section Order :
356